{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:19:10Z","timestamp":1778685550977,"version":"3.51.4"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fed Pract"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.12788\/fp.0714","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:48:51Z","timestamp":1778683731000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network"],"prefix":"10.12788","volume":"43","author":[{"given":"Kirsten","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2026,5,1]]},"container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/0526FED%20AVAHO%20TKI.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:48:52Z","timestamp":1778683732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/273373\/potential-tyrosine-kinase-inhibitor-therapy-discontinuation-patients-chronic-myeloid-leukemia-va-regional-network"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":0,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0714","relation":{},"ISSN":["1078-4497","1945-337X"],"issn-type":[{"value":"1078-4497","type":"print"},{"value":"1945-337X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}